UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 682

Sortiert nach

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351

The New England journal of medicine, 2021-06, Vol.384 (24), p.2352-2354

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Cell host & microbe, 2021-04, Vol.29 (4), p.529-539.e3

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

The New England journal of medicine, 2020-12, Vol.383 (24), p.2320-2332

2020

Link zum Volltext

Verfügbarkeit prüfen

A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine

The New England journal of medicine, 2013-12, Vol.369 (26), p.2564-2566

2013

Link zum Volltext

Verfügbarkeit prüfen

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

PLoS medicine, 2021-10, Vol.18 (10), p.e1003769-e1003769

2021

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

The Journal of infectious diseases, 2016-02, Vol.213 (3), p.411-422

2016

Link zum Volltext

Verfügbarkeit prüfen

Solution blow spinning: A new method to produce micro- and nanofibers from polymer solutions

Journal of applied polymer science, 2009-08, Vol.113 (4), p.2322-2330

2009

Link zum Volltext

Verfügbarkeit prüfen

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Scientific reports, 2023-01, Vol.13 (1), p.1222-1222, Article 1222

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Vaccine, 2013-01, Vol.31 (3), p.524-532

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine

Expert review of vaccines, 2023-12, Vol.22 (1), p.501-517

2023

Link zum Volltext

Verfügbarkeit prüfen

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets

Virology (New York, N.Y.), 2017-09, Vol.509 (C), p.90-97

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

Immunity & ageing, 2017-04, Vol.14 (1), p.8-8, Article 8

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Starch and Paperboard Reinforcing Structures on Insulative Fiber Foam Composites

Polymers, 2024-04, Vol.16 (7), p.911

2024

Link zum Volltext

Verfügbarkeit prüfen

Application of Cellulose Microfibrils in Polymer Nanocomposites

Journal of polymers and the environment, 2005-10, Vol.13 (4), p.301-306

2005

Link zum Volltext

Verfügbarkeit prüfen

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

Vaccines (Basel), 2020-02, Vol.8 (1), p.99

2020

Link zum Volltext

Verfügbarkeit prüfen

Toxin-Mediated Effects on the Innate Mucosal Defenses: Implications for Enteric Vaccines

Infection and Immunity, 2009-12, Vol.77 (12), p.5206-5215

2009

Link zum Volltext

Verfügbarkeit prüfen

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

Vaccine, 2014-05, Vol.32 (26), p.3169-3174

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum

Infection and Immunity, 2007-05, Vol.75 (5), p.2163-2170

2007

Link zum Volltext

Verfügbarkeit prüfen

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

Vaccine, 2017-03, Vol.35 (12), p.1586-1589

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

The Journal of infectious diseases, 2019-10, Vol.220 (11), p.1802-1815

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

Vaccine, 2017-06, Vol.35 (30), p.3749-3759

2017

Link zum Volltext

Verfügbarkeit prüfen

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch

Vaccine, 2008-05, Vol.26 (22), p.2782-2787

2008

Link zum Volltext

Verfügbarkeit prüfen

Use of Microscopy To Assess Bran Removal Patterns in Milled Rice

Journal of agricultural and food chemistry, 2012-07, Vol.60 (28), p.6960-6965

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 682

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(627)
Mit Volltextzugriff
(632)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(480)
Life Sciences & Biomedicine
(375)
Humans
(243)
Female
(145)
Biological And Medical Sciences
(137)
Male
(135)
Animals
(124)
Physical Sciences
(100)
Medical Sciences
(82)
Adult
(79)
Middle Aged
(75)
Fundamental And Applied Biological Sciences. Psychology
(64)
Immunology
(60)
Aged
(56)
Chemistry
(53)
Mice
(50)
Vaccines
(42)
Technology
(41)
Adolescent
(40)
Microbiology
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

Solution blow spinning: A new method to produce micro- and nanofibers from polymer solutions

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

Effect of Starch and Paperboard Reinforcing Structures on Insulative Fiber Foam Composites

Application of Cellulose Microfibrils in Polymer Nanocomposites

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Toxin-Mediated Effects on the Innate Mucosal Defenses: Implications for Enteric Vaccines

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch

Use of Microscopy To Assess Bran Removal Patterns in Milled Rice

Suchergebnisse filtern